2013 -- H 5961

=======

LC02294

=======

STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2013

____________

A N A C T

RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

     Introduced By: Representatives Carnevale, Corvese, O'Brien, Costantino, and Lombardi

     Date Introduced: April 04, 2013

     Referred To: House Health, Education & Welfare

It is enacted by the General Assembly as follows:

1-1

     SECTION 1. Section 21-28-3.18 of the General Laws in Chapter 21-28 entitled "Uniform

1-2

Controlled Substances Act" is hereby amended to read as follows:

1-3

     21-28-3.18. Prescriptions. -- (a) An apothecary in good faith may sell and dispense

1-4

controlled substances in schedule II to any person upon a written prescription by a practitioner

1-5

licensed by law to prescribe or administer those substances, dated and signed by the person

1-6

prescribing on the day when issued and bearing the full name and address of the patient to whom,

1-7

or of the owner of the animal for which the substance is dispensed and the full name, address and

1-8

registration number under the federal law of the person prescribing, if he or she is required by that

1-9

law to be registered. If the prescription is for an animal, it shall state the species of the animal for

1-10

which the substance is prescribed.

1-11

      (b) The apothecary filling the prescription shall sign his or her full name and shall write

1-12

the date of filling on the face of the prescription.

1-13

      (c) The prescription shall be retained on file by the proprietor of the pharmacy in which

1-14

it was filled for a period of two (2) years so as to be readily accessible for inspection by any

1-15

public officer or employee engaged in the enforcement of this chapter.

1-16

      (d) (1) Prescriptions for controlled substances in schedule II shall be filed separately and

1-17

shall not be refilled.

1-18

      (2) The director of health may, after appropriate notice and hearing pursuant to section

1-19

42-35-3, promulgate rules and regulations for the purpose of adopting a system for electronic data

1-20

transmission of prescriptions for controlled substances in schedule II and III.

2-1

      (e) A prescription for a schedule II narcotic substance to be compounded for the direct

2-2

administration to a patient by parenteral, intravenous, intramuscular, subcutaneous, or intraspinal

2-3

infusion may be transmitted by the practitioner or practitioner's agent to the pharmacy by

2-4

facsimile. The facsimile will serve as the original prescription.

2-5

      (f) A prescription written for a schedule II substance for a resident of a long term care

2-6

facility may be transmitted by the practitioner or the practitioner's agent to the dispensing

2-7

pharmacy by facsimile. The facsimile serves as the original prescription.

2-8

      (g) A prescription for a schedule II narcotic substance for a patient residing in a hospice

2-9

certified by Medicare under title XVIII of the Social Security Act, 42 U.S.C. section 1395 et seq.,

2-10

or licensed by the state, may be transmitted by the practitioner or practitioner's agent to the

2-11

dispensing pharmacy by facsimile. The practitioner or the practitioner's agent will note on the

2-12

prescription that the patient is a hospice patient. The facsimile serves as the original written

2-13

prescription.

2-14

      (h) An apothecary, in lieu of a written prescription, may sell and dispense controlled

2-15

substances in schedules III, IV, and V to any person upon an oral prescription of a practitioner. In

2-16

issuing an oral prescription the prescriber shall furnish the apothecary with the same information

2-17

as is required by subsection (a) of this section in the case of a written prescription for controlled

2-18

substances in schedule II, except for the written signature of the person prescribing, and the

2-19

apothecary who fills the prescription, shall immediately reduce the oral prescription to writing

2-20

and shall inscribe the information on the written record of the prescription made. This record shall

2-21

be filed and preserved by the proprietor of the pharmacy in which it is filled in accordance with

2-22

the provisions of subsection (c) of this section. In no case may a prescription for a controlled

2-23

substance listed in schedules III, IV, or V be filled or refilled more than six (6) months after the

2-24

date on which the prescription was issued and no prescription shall be authorized to be refilled

2-25

more than five (5) times. Each refilling shall be entered on the face or back of the prescription

2-26

and note the date and amount of controlled substance dispensed, and the initials or identity of the

2-27

dispensing apothecary.

2-28

      (i) In the case of an emergency situation as defined in federal law, an apothecary may

2-29

dispense a controlled substance listed in schedule II upon receiving an oral authorization of a

2-30

prescribing practitioner provided that:

2-31

      (1) The quantity prescribed and dispensed is limited to the amount adequate to treat the

2-32

patient during the emergency period and dispensing beyond the emergency period must be

2-33

pursuant to a written prescription signed by the prescribing practitioner.

3-34

      (2) The prescription shall be immediately reduced to writing and shall contain all the

3-35

information required in subsection (a) of this section.

3-36

      (3) The prescription must be dispensed in good faith in the normal course of professional

3-37

practice.

3-38

      (4) Within seven (7) days after authorizing an emergency oral prescription, the

3-39

prescribing practitioner shall cause a written prescription for the emergency quantity prescribed to

3-40

be delivered to the dispensing apothecary. The prescription shall have written on its face

3-41

"Authorization for emergency dispensing" and the date of the oral order. The written prescription

3-42

upon receipt by the apothecary shall be attached to the oral emergency prescription which had

3-43

earlier been reduced to writing.

3-44

      (j) (1) The partial filling of a prescription for a controlled substance listed in schedule II

3-45

is permissible, if the apothecary is unable to supply the full quantity called for in a written

3-46

prescription or emergency oral prescription and he or she makes a notation of the quantity

3-47

supplied on the face of the written prescription or oral emergency prescription which has been

3-48

reduced to writing. The remaining portion of the prescription may be filled within seventy-two

3-49

(72) hours of the first partial filling, however, if the remaining portion is not, or cannot be filled

3-50

within seventy-two (72) hours, the apothecary shall notify the prescribing practitioner. No further

3-51

quantity may be supplied beyond seventy-two (72) hours without a new prescription.

3-52

      (2) (i) A prescription for a schedule II controlled substance written for a patient in a long

3-53

term care facility (LTCF), or for a patient with a medical diagnosis documenting a terminal

3-54

illness, may be filled in partial quantities to include individual dosage units. If there is a question

3-55

whether a patient may be classified as having a terminal illness, the pharmacist must contact the

3-56

practitioner prior to partially filling the prescription. Both the pharmacist and the prescribing

3-57

practitioner have a corresponding responsibility to assure that the controlled substance is for a

3-58

terminally ill patient.

3-59

      (ii) The pharmacist must record on the prescription whether the patient is "terminally ill"

3-60

or an "LTCF patient." A prescription that is partially filled, and does not contain the notation

3-61

"terminally ill" or "LTCF patient", shall be deemed to have been filled in violation of this chapter.

3-62

      (iii) For each partial filling, the dispensing pharmacist shall record on the back of the

3-63

prescription (or on another appropriate record, uniformly maintained, and readily retrievable),

3-64

the:

3-65

      (A) Date of the partial filling;

3-66

      (B) Quantity dispensed;

3-67

      (C) Remaining quantity authorized to be dispensed; and

4-68

      (D) Identification of the dispensing pharmacist.

4-69

      (iv) The total quantity of schedule II controlled substances dispensed in all partial fillings

4-70

must not exceed the total quantity prescribed.

4-71

      (v) Schedule II prescriptions for patients in a LTCF, or patients with a medical diagnosis

4-72

documenting a terminal illness, are valid for a period not to exceed sixty (60) days from the issue

4-73

date, unless sooner terminated by the discontinuance of medication.

4-74

      (k) Automated data processing systems. - As an alternative to the prescription record

4-75

keeping provision of subsection (h) of this section, an automated data processing system may be

4-76

employed for the record keeping system, if the following conditions have been met:

4-77

      (1) The system shall have the capability of producing sight-readable documents of all

4-78

original and refilled prescription information. The term "sight-readable" means that an authorized

4-79

agent shall be able to examine the record and read the information. During the course of an on-

4-80

site inspection, the record may be read from the CRT, microfiche, microfilm, printout, or other

4-81

method acceptable to the director. In the case of administrative proceedings, records must be

4-82

provided in a paper printout form.

4-83

      (2) The information shall include, but not be limited to, the prescription requirements

4-84

and records of dispensing as indicated in subsection (h) of this section.

4-85

      (3) The individual pharmacist responsible for completeness and accuracy of the entries

4-86

to the system must provide documentation of the fact that prescription information entered into

4-87

the computer is correct. In documenting this information, the pharmacy shall have the option to

4-88

either:

4-89

      (i) Maintain a bound log book, or separate file, in which each individual pharmacist

4-90

involved in the dispensing shall sign a statement each day, attesting to the fact that the

4-91

prescription information entered into the computer that day has been reviewed and is correct as

4-92

shown. The book or file must be maintained at the pharmacy employing that system for a period

4-93

of at least two (2) years after the date of last dispensing; or

4-94

      (ii) Provide a printout of each day's prescription information. That printout shall be

4-95

verified, dated, and signed by the individual pharmacist verifying that the information indicated is

4-96

correct. The printout must be maintained at least two (2) years from the date of last dispensing.

4-97

      (4) An auxiliary record keeping system shall be established for the documentation of

4-98

refills, if the automated data processing system is inoperative for any reason. The auxiliary

4-99

system shall ensure that all refills are authorized by the original prescription, and that the

4-100

maximum number of refills is not exceeded. When this automated data processing system is

4-101

restored to operation, the information regarding prescriptions filled and refilled during the

4-102

inoperative period, shall be entered into the automated data processing system within ninety-six

5-1

(96) hours.

5-2

      (5) Any pharmacy using an automated data processing system must comply with all

5-3

applicable state and federal laws and regulations.

5-4

      (6) A pharmacy shall make arrangements with the supplier of data processing services or

5-5

materials to ensure that the pharmacy continues to have adequate and complete prescription and

5-6

dispensing records if the relationship with the supplier terminates for any reason. A pharmacy

5-7

shall ensure continuity in the maintenance of records.

5-8

      (7) The automated data processing system shall contain adequate safeguards for security

5-9

of the records, to maintain the confidentiality and accuracy of the prescription information.

5-10

Safeguards against unauthorized changes in data after the information has been entered and

5-11

verified by the registered pharmacist shall be provided by the system.

5-12

      (l) Prescriptions for controlled substances as found in schedules II, will become void

5-13

unless dispensed within ninety (90) days of the original date of the prescription, and in . In no

5-14

event shall more than a thirty (30) day supply be dispensed at any one time, unless the prescribing

5-15

physician certifies that the patient has been prescribed said controlled substance for a continuous

5-16

period of twelve (12) months and that the patient will require said controlled substance for at least

5-17

an additional ninety (90) day period, then, said controlled substance may be prescribed and

5-18

dispensed for not more than a ninety (90) day supply at any one time.

5-19

      (1) In prescribing controlled substances in schedule II, practitioners may write up to

5-20

three (3) separate prescriptions, each for up to a one-month supply, each signed and dated on the

5-21

date written. For those prescriptions for the second and/or third month, the practitioner must write

5-22

the earliest date each of those subsequent prescription may be filled, with directions to the

5-23

pharmacist to fill no earlier than the date specified on the face of the prescription.

5-24

      (m) The prescriptions in schedules III, IV, and V will become void unless dispensed

5-25

within one hundred eighty (180) days of the original date of the prescription. For purposes of this

5-26

section, a "dosage unit" shall be defined as a single capsule, tablet or suppository, or not more

5-27

than one five (5) ml. of an oral liquid.

5-28

      (1) Prescriptions in Schedule III cannot be written for more than one hundred (100)

5-29

dosage units and not more than one hundred (100) dosage units may be dispensed at one time.

5-30

      (2) Prescriptions in Schedule IV and V may be written for up to a ninety (90) day supply

5-31

based on directions. No more than three hundred and sixty (360) dosage units may be dispensed

5-32

at one time.

5-34

SECTION 2. This act shall take effect upon passage.

=======

LC02294

========

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N A C T

RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

***

7-1

     This act would provide that a prescription for a Schedule II controlled substance may be

7-2

prescribed for up to a ninety (90) day supply provided the prescribing physician certifies that the

7-3

patient has been prescribed the controlled substance for a continuous period of twelve (12)

7-4

months and that the patient would require the controlled substance for at least an additional ninety

7-5

(90) day period.

7-6

     This act would take effect upon passage.

=======

LC02294

=======